$EXAS
EXACT SCIENCES CORP

2020 Q2 Form 10-Q Financial Statement

#000112414020000051 Filed on July 31, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $268.9M $199.9M
YoY Change 34.52% 94.25%
Cost Of Revenue $77.89M $51.14M
YoY Change 52.31% 92.59%
Gross Profit $170.4M $148.3M
YoY Change 14.91% 95.13%
Gross Profit Margin 63.38% 74.2%
Selling, General & Admin $225.5M $151.9M
YoY Change 48.47% 61.68%
% of Gross Profit 132.35% 102.43%
Research & Development $32.67M $29.97M
YoY Change 9.01% 106.97%
% of Gross Profit 19.17% 20.21%
Depreciation & Amortization $17.60M $7.100M
YoY Change 147.89% 39.22%
% of Gross Profit 10.33% 4.79%
Operating Expenses $237.4M $182.2M
YoY Change 30.31% 67.61%
Operating Profit -$67.01M -$33.90M
YoY Change 97.66% 3.67%
Interest Expense $22.91M $12.71M
YoY Change 80.24% 47.76%
% of Operating Profit
Other Income/Expense, Net -$1.388M -$5.043M
YoY Change -72.48% 36.81%
Pretax Income -$68.40M -$38.95M
YoY Change 75.62% 7.03%
Income Tax -$305.0K -$443.0K
% Of Pretax Income
Net Earnings -$68.09M -$38.50M
YoY Change 76.85% 5.81%
Net Earnings / Revenue -25.33% -19.26%
Basic Earnings Per Share -$0.45 -$0.30
Diluted Earnings Per Share -$0.45 -$0.30
COMMON SHARES
Basic Shares Outstanding 149.7M shares 129.2M shares
Diluted Shares Outstanding 149.7M shares 129.2M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.223B $1.239B
YoY Change -1.35% 1.41%
Cash & Equivalents $703.9M $205.1M
Short-Term Investments $518.7M $1.034B
Other Short-Term Assets $36.40M $23.70M
YoY Change 53.59% 43.64%
Inventory $82.22M $47.78M
Prepaid Expenses
Receivables $163.6M $63.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.505B $1.375B
YoY Change 9.46% 4.92%
LONG-TERM ASSETS
Property, Plant & Equipment $463.4M $335.5M
YoY Change 38.13% 138.79%
Goodwill $1.238B $17.28M
YoY Change 7062.87%
Intangibles $1.105B
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.90M $26.60M
YoY Change -10.15% 202.3%
Total Long-Term Assets $2.963B $407.1M
YoY Change 627.72% 136.16%
TOTAL ASSETS
Total Short-Term Assets $1.505B $1.375B
Total Long-Term Assets $2.963B $407.1M
Total Assets $4.468B $1.782B
YoY Change 150.72% 20.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.00M $19.90M
YoY Change 55.8% 80.87%
Accrued Expenses $139.5M $151.0M
YoY Change -7.62% 135.22%
Deferred Revenue $30.70M $700.0K
YoY Change 4285.71%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $312.0M
YoY Change -99.58% 6682.61%
Total Short-Term Liabilities $222.3M $492.5M
YoY Change -54.86% 493.33%
LONG-TERM LIABILITIES
Long-Term Debt $1.557B $494.0M
YoY Change 215.24% -23.86%
Other Long-Term Liabilities $50.31M $29.92M
YoY Change 68.13% 360.37%
Total Long-Term Liabilities $50.31M $29.92M
YoY Change 68.13% -95.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $222.3M $492.5M
Total Long-Term Liabilities $50.31M $29.92M
Total Liabilities $1.957B $1.016B
YoY Change 92.5% 37.67%
SHAREHOLDERS EQUITY
Retained Earnings -$1.312B -$1.157B
YoY Change 13.34%
Common Stock $3.821B $1.921B
YoY Change 98.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.887B $765.5M
YoY Change
Total Liabilities & Shareholders Equity $4.468B $1.782B
YoY Change 150.72% 20.18%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$68.09M -$38.50M
YoY Change 76.85% 5.81%
Depreciation, Depletion And Amortization $17.60M $7.100M
YoY Change 147.89% 39.22%
Cash From Operating Activities -$6.900M $17.00M
YoY Change -140.59% -166.67%
INVESTING ACTIVITIES
Capital Expenditures -$21.00M -$69.00M
YoY Change -69.57% 137.11%
Acquisitions
YoY Change
Other Investing Activities $14.50M -$33.50M
YoY Change -143.28% -67.06%
Cash From Investing Activities -$6.400M -$102.5M
YoY Change -93.76% -21.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.10M 5.500M
YoY Change 192.73% -97.64%
NET CHANGE
Cash From Operating Activities -6.900M 17.00M
Cash From Investing Activities -6.400M -102.5M
Cash From Financing Activities 16.10M 5.500M
Net Change In Cash 2.800M -80.00M
YoY Change -103.5% -203.9%
FREE CASH FLOW
Cash From Operating Activities -$6.900M $17.00M
Capital Expenditures -$21.00M -$69.00M
Free Cash Flow $14.10M $86.00M
YoY Change -83.6% 2288.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Regulatory Liability Amortization Period
RegulatoryLiabilityAmortizationPeriod
P2Y
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001124140
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35092
dei Entity Registrant Name
EntityRegistrantName
EXACT SCIENCES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0478229
dei Entity Address Address Line1
EntityAddressAddressLine1
5505 Endeavor Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Madison
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53719
dei City Area Code
CityAreaCode
608
dei Local Phone Number
LocalPhoneNumber
535-8815
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
EXAS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150167320 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
703926000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177254000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
518731000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
146401000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
163608000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130667000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
82215000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
61724000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36378000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40913000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1504858000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
556959000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20293000 USD
CY2020Q2 us-gaap Assets
Assets
4467735000 USD
CY2019Q4 us-gaap Assets
Assets
3505768000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
463437000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455325000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
132751000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126444000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1237672000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1203197000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1105115000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1143550000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23902000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30998000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25973000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139505000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
193329000 USD
CY2020Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
22944000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9871000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7891000 USD
CY2020Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1319000 USD
CY2019Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
834000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40581000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8467000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
222274000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
236494000 USD
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1534383000 USD
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
803605000 USD
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
24032000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50311000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34911000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126630000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118665000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1956542000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Liabilities
Liabilities
1217707000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149980798 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149980798 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147625696 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147625696 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1501000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1477000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3819798000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3406440000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1489000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1311595000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1119756000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2511193000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2288061000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4467735000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3505768000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
268868000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
199870000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
616689000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
361913000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
77892000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
51139000 USD
us-gaap Cost Of Revenue
CostOfRevenue
159498000 USD
us-gaap Cost Of Revenue
CostOfRevenue
93966000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32673000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29972000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76182000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61757000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
118862000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
88190000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
286611000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
179129000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106685000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63723000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
220676000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
127529000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23430000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
748000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46769000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1508000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
359542000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
233772000 USD
us-gaap Costs And Expenses
CostsAndExpenses
789736000 USD
us-gaap Costs And Expenses
CostsAndExpenses
463889000 USD
CY2020Q2 us-gaap Other Operating Income
OtherOperatingIncome
23665000 USD
CY2019Q2 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
23665000 USD
us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-67009000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-33902000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-149382000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-101976000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2912000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7669000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3009000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
14324000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22912000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12712000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-48065000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-34702000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20000000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5043000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-45056000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20378000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87009000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38945000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-194438000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122354000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-867000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-443000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2599000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-913000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-86142000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-38502000 USD
us-gaap Net Income Loss
NetIncomeLoss
-191839000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121441000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149727000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
129182000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
148938000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
127723000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-86142000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-38502000 USD
us-gaap Net Income Loss
NetIncomeLoss
-191839000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121441000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3206000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1952000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1564000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4128000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
25000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
CY2020Q2 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-82936000 USD
CY2019Q2 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-36550000 USD
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-190250000 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-117313000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
464000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
984000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82936000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37014000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-190250000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118297000 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2288061000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
346641000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-64199000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
12007000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29560000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28597000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-105697000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1617000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2537653000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6638000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
40039000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9799000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-86142000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3206000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2511193000 USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
680941000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
268390000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
182435000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-300768000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3650000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
7409000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16166000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-82939000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1656000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
776940000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-22000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1348000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20143000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4137000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-38502000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1488000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
765532000 USD
us-gaap Profit Loss
ProfitLoss
-191839000 USD
us-gaap Profit Loss
ProfitLoss
-121441000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33632000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13507000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-650000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-211000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-333000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3222000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-984000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
69599000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36309000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7954000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10558000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
34638000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
19798000 USD
exas Amortization Of Deferred Financing Costs Credits And Other Liabilities
AmortizationOfDeferredFinancingCostsCreditsAndOtherLiabilities
-2505000 USD
exas Amortization Of Deferred Financing Costs Credits And Other Liabilities
AmortizationOfDeferredFinancingCostsCreditsAndOtherLiabilities
-847000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
503000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
-2580000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46769000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1508000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
6860000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1762000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30644000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18574000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20260000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8633000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4997000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1607000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-47587000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25725000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-43419000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
11920000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56697000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57208000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
640085000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
511587000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
268483000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
447674000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33455000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79448000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6654000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
516000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
380000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-412227000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143741000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1125547000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
729479000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10938000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4998000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9799000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4137000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150054000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
493356000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-626000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
319000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
995604000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
245577000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
526680000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44628000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177528000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160430000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
704208000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205058000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
8684000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
24402000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1564000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
4128000 USD
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
136559 shares
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
86532 shares
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
12007000 USD
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
7409000 USD
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
2158991 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
182435000 USD
exas Debt Instrument Convertible Equity Component Consideration Settled
DebtInstrumentConvertibleEquityComponentConsiderationSettled
-64199000 USD
exas Debt Instrument Convertible Equity Component Consideration Settled
DebtInstrumentConvertibleEquityComponentConsiderationSettled
-300768000 USD
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
382947 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28597000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
us-gaap Interest Paid Net
InterestPaidNet
3908000 USD
us-gaap Interest Paid Net
InterestPaidNet
1216000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of convertible notes, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2019 Form 10-K.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The spread of the coronavirus (“COVID-19”) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The COVID-19 outbreak, which the World Health Organization has classified as a pandemic, has prompted governments and regulatory bodies throughout the world to enact broad precautionary measures, including “stay-at-home” orders, restrictions on the performance of “non-essential” services, public gatherings and travel. Health systems, including key markets where the Company operates, have been, or may be, overwhelmed with high volumes of patients suffering from COVID-19.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2020 and through the date of the filing of this Quarterly Report </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company’s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div>
CY2020Q2 exas Coronavirus Aid Relief And Economic Securities Cares Act Funds Received
CoronavirusAidReliefAndEconomicSecuritiesCARESActFundsReceived
23700000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27546000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18707000 shares
CY2020Q2 exas Coronavirus Aid Relief And Economic Securities Cares Act Funds Received
CoronavirusAidReliefAndEconomicSecuritiesCARESActFundsReceived
23700000 USD
exas Minimum Contractual Term Of Certain Current Investments Which Can Be Liquidated
MinimumContractualTermOfCertainCurrentInvestmentsWhichCanBeLiquidated
P1Y
CY2020Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
35713000 USD
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
24958000 USD
CY2020Q2 exas Inventory Finished Semi Finished Goods
InventoryFinishedSemiFinishedGoods
46502000 USD
CY2019Q4 exas Inventory Finished Semi Finished Goods
InventoryFinishedSemiFinishedGoods
36766000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
82215000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
61724000 USD
CY2020Q2 exas Number Of Stages Of Software Development
NumberOfStagesOfSoftwareDevelopment
3 stagesInSoftwareDevelopment
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
exas Lessee Operating Lease Option To Terminate Period
LesseeOperatingLeaseOptionToTerminatePeriod
P1Y
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassifications</span></div><div style="text-indent:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements including the amortization of acquired intangible assets, which is now presented as a separate line item on the Company's condensed consolidated statements of operations and was previously included in cost of sales, research and development, and general and administrative expenses. Due to these reclassifications, the Company is no longer presenting gross margin on the Company's condensed consolidated statements of operations.</span></div>
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
268868000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
199870000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
616689000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
361913000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
600000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19000 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
704208000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
177528000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
93724000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
87000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
175007000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1385000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1716000 USD
CY2020Q2 us-gaap Marketable Securities
MarketableSecurities
518731000 USD
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
146401000 USD
CY2020Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1222939000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
323929000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
762764000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1492000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
764253000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
175082000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
678771000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
679587000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
83993000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
84666000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
181909000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
181909000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
200000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
200000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
300000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
400000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
300000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
573665000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
532956000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110228000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77631000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
463437000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455325000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
17600000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
7100000 USD
us-gaap Depreciation
Depreciation
33400000 USD
us-gaap Depreciation
Depreciation
13400000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
972056000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
94012000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
67433000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
904623000 USD
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1172548000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
67433000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1105115000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
963690000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20411000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
943279000 USD
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1163961000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20411000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1143550000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
47158000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
94217000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
93345000 USD
CY2020Q2 exas Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
482167000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
904623000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
17279000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1203197000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1237672000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2879000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-344000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
4128000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
exas Business Combination Contingent Consideration Gain Loss Recognized
BusinessCombinationContingentConsiderationGainLossRecognized
0 USD
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
328000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2551000 USD
CY2019Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
17000000.0 shares
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
400000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
400000 shares
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
1564000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-25000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1589000 USD
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
3784000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
0 USD
CY2020Q2 exas Number Of Employees Performance Based Equity Awards Impacted By Change In Operational Milestones
NumberOfEmployeesPerformanceBasedEquityAwardsImpactedByChangeInOperationalMilestones
36 employees
exas Number Of Employees Performance Based Equity Awards Impacted By Change In Operational Milestones
NumberOfEmployeesPerformanceBasedEquityAwardsImpactedByChangeInOperationalMilestones
36 employees
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
984000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40000000.0 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36300000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
0 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
1800000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
12289000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2419000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126400000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13024000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20511000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
132800000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
136500000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9900000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126600000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
126600000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7900000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118700000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0683
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10600000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8000000.0 USD
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
86.94
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1139000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
645000 USD
CY2020Q2 exas Coupon Interest Expense
CouponInterestExpense
2567000 USD
CY2019Q2 exas Coupon Interest Expense
CouponInterestExpense
1739000 USD
exas Coupon Interest Expense
CouponInterestExpense
4498000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1961000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1330000 USD
CY2020Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18946000 USD
CY2019Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10074000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
32677000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18468000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7954000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10558000 USD
exas Coupon Interest Expense
CouponInterestExpense
3846000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
22652000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
12458000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
47090000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
34202000 USD
CY2020Q2 us-gaap Interest Expense Other
InterestExpenseOther
260000 USD
CY2019Q2 us-gaap Interest Expense Other
InterestExpenseOther
254000 USD
us-gaap Interest Expense Other
InterestExpenseOther
975000 USD
us-gaap Interest Expense Other
InterestExpenseOther
500000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
22912000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
12712000 USD
us-gaap Interest Expense
InterestExpense
48065000 USD
us-gaap Interest Expense
InterestExpense
34702000 USD
CY2020Q1 us-gaap Business Combination Consideration Transferred Including Equity Interest In Acquiree Held Prior To Combination1
BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
8400000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10200000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11300000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
268868000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
199870000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
616689000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
361913000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-900000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
26500000 USD

Files In Submission

Name View Source Status
0001124140-20-000051-index-headers.html Edgar Link pending
0001124140-20-000051-index.html Edgar Link pending
0001124140-20-000051.txt Edgar Link pending
0001124140-20-000051-xbrl.zip Edgar Link pending
a0630202010qexhibit101.htm Edgar Link pending
a0630202010qexhibit102.htm Edgar Link pending
a0630202010qexhibit103.htm Edgar Link pending
a0630202010qexhibit311.htm Edgar Link pending
a0630202010qexhibit312.htm Edgar Link pending
a0630202010qexhibit321.htm Edgar Link pending
exas-20200630.htm Edgar Link pending
exas-20200630.xsd Edgar Link pending
exas-20200630_cal.xml Edgar Link unprocessable
exas-20200630_def.xml Edgar Link unprocessable
exas-20200630_htm.xml Edgar Link completed
exas-20200630_lab.xml Edgar Link unprocessable
exas-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending